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The developing child (fetus to prepuberty) is
particularly susceptible to environmental insult,
because development is a highly integrated
process in which high rates of proliferation and
extensive differentiation are coordinated with
each other and with programmed cell death.
Rapid growth rates allow for mutagenic and
epigenetic alterations as cells proliferate.
Likewise, differentiation represents a highly
controlled process in which patterns of gene
expression undergo massive changes. Thus,
both cell division and differentiation offer
multiple opportunities for the initiation of
lesions as well as the promotion of the growth
of altered cells; these are hallmarks of the com-
plex process known as cancer. In addition,
physiologic protective barriers such as the pla-
centa and the blood–brain barrier are not
complete in utero. Further, the metabolizing
and elimination capabilities of the developing
organism are not fully developed until after
birth (Miller 1983), leaving the fetus and
newborn particularly susceptible to adverse
effects of environmental compounds.
Developmental Carcinogens 
in Humans
Early childhood exposures to infectious agents
are key determinants for both hepatocellular
carcinoma (Hsieh et al. 1992) and acute lym-
phoblastic leukemia (ALL; Greaves 1997).
However, exposure to environmental com-
pounds in utero—a proliferative period in
human development—has long been thought
to be critically involved in the causation of
cancers in children and young adults.
Although a wide range of potentially harmful
agents may be involved, there is unequivocal
evidence for two environmental agents: ioniz-
ing radiation and the estrogen agonist diethyl-
stilbestrol (DES) (Anderson et al. 2000). The
clear evidence for the role of ionizing radiation
comes from studies involving diagnostic
assessment of pregnant women. Doll and
Wakeford (1997) have concluded that low
doses of X ray to the fetus, especially during
the last trimester, cause an increased risk of
leukemia and all other types of cancer during
childhood. In addition, therapeutic X ray of
infants is also associated with thyroid and
breast cancer later in life (Boice and Miller
1999). The clear association between fetal
exposure to DES and vaginal adenocarcinoma
in those young women (Herbst et al. 1971)
led to the suggestion that developmental expo-
sure to other hormonally active substances
could also be associated with delayed cancer.
There is evidence for an association
between prenatal exposure to a variety of envi-
ronmental insults and childhood cancers. Both
the timing and the chemical species may con-
tribute to the actual risk of cancer to the child.
Parental occupational exposure to various
chemicals correlates with an increased inci-
dence of brain tumors in their offspring (Peters
et al. 1981). Shu et al. (1999) have recently
shown that parental exposure to hydrocarbons
is related to an increased risk of ALL in their
children, and that preconceptional paternal
exposure and postnatal maternal exposure to a
variety of plastics was associated with an
increased risk of childhood ALL. Maternal
exposure to solvents, paints, or paint thinners
from preconception to birth has a reported
association with an increased risk of ALL.
Freedman et al. (2001) recently reported an
association between household organic solvent
exposure and childhood ALL, including chil-
dren whose mothers had painted extensively in
the year before the child’s birth. Parental use of
pesticides has been associated with an increased
risk of childhood leukemia or lymphoma
(Meinert et al. 2000). Speciﬁcally, children liv-
ing on farms may be at increased risk of
leukemia, as the use of household pesticides,
either by parents or professional applicators,
was associated with childhood lymphoma.
Alexander et al. (2001) recently demonstrated
that in utero exposure to chemicals is associated
with an elevated risk of acute leukemia in
infants. The carbamate pesticide propoxur is
one environmental chemical identiﬁed where
exposure was highly correlated with leukemia
in the offspring. Parental cigarette smoking
has also been linked to childhood cancer
(Pershagen 1989; Stjernfeldt et al. 1986). Even
with several identiﬁed developmental triggers
in the environment, it should be noted that
because childhood cancers are so rare, it is very
difﬁcult to conduct prospective epidemiologic
studies following toxicant exposures because
large longitudinal studies would be required.
Early Life-Stage Carcinogens 
in Animal Models
The data from experimental animal studies for
developmental exposures and early life-stage or
adult cancer are far more extensive and con-
vincing than the current epidemiologic data.
Many of the animal data are well correlated
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Developing organisms have increased susceptibility to cancer if they are exposed to environmental
toxicants during rapid growth and differentiation. Human studies have demonstrated clear increases
in cancer after prenatal exposure to ionizing radiation, and there is suggestive evidence that brain
tumors and leukemia are associated with parental exposures to chemicals. Animal experiments have
demonstrated increased tumor formation induced by prenatal or neonatal exposure to a variety of
chemicals, including direct-acting carcinogens and drugs. Recently, natural estrogens have been clas-
siﬁed as known human carcinogens. Prenatal exposure to natural and synthetic estrogens is associ-
ated with increases in breast and vaginal tumors in humans as well as uterine tumors in animals.
Synthetic halogenated chemicals increase liver tumors after early life-stage exposure. Recently, a
prototypical endocrine-disrupting compound, 2,3,7,8-tetrachlorodibenzo-p-dioxin, has been shown
to be a developmental toxicant of the mammary gland in rodents. Dioxin alters multiple endocrine
systems, and its effects on the developing breast involve delayed proliferation and differentiation of
the mammary gland, as well as an elongation of the window of sensitivity to potential carcinogens.
Implications of these new ﬁndings suggest that causes of endocrine-related cancers or susceptibility
to cancer may be a result of developmental exposures rather than exposures existing at or near the
time of tumor detection. Key words: animal models, atrazine, carcinogenesis, childhood cancers,
development, dioxin, endocrine disruptors. Environ Health Perspect 111:389–394 (2003).
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Research Reviewwith human data, whereas other data indicate
compounds that deserve further study in
human populations. A variety of types of
radiation (e.g., X ray, ultraviolet) and chemi-
cals given before mating, during pregnancy,
or directly to the neonate can lead to an
increased incidence of neoplasms in the off-
spring (Tomatis 1989). Preconceptional expo-
sures during sperm or oocyte maturation have
led to transgenerational carcinogenesis for sev-
eral types of radiation and a variety of chemi-
cal carcinogens (reviewed in Tomatis 1989).
For example, ethyl-nitrosourea (ENU) led to
nervous system tumors in rats, and X ray
caused lung tumors in mice. Urethane caused
lung and liver tumors in mice, but the partic-
ular response was strain specific. Depending
on periconceptional day, exposure to N-
nitrosodiethylamine (NDEA) caused a variety
of tumor types in hamsters. The actual effects
of preconceptional exposure to these carcino-
gens seemed to vary with chemical, dose, and
genetics. However, recent work by Yu et al.
(1999) demonstrated that preconception
exposure of the parental male mouse affected
neoplastic changes in nearly all tissues in
which tumors occur naturally with aging.
Anderson et al. (2000) have extensively
reviewed the literature on carcinogenesis in off-
spring with environmental exposures to known
carcinogens during gestation, and a summary
of key ﬁndings is provided. In some cases the
number of tumors (incidence or multiplicity)
in exposed offspring were greatly increased
after early life-stage exposure; in others, the
time to spontaneous tumors (latency) was
decreased by exposure. Because one would
expect that direct carcinogens would consis-
tently induce tumors in exposed offspring, the
significance of the timing of developmental
exposure must be reiterated. Skin carcinogene-
sis has been caused by prenatal X ray in mice.
Transplacental initiation, followed by addi-
tional treatment with the chemical carcinogen
dimethylbenz[a]anthracene (DMBA) after
birth, also increased skin tumors in mice.
Exposure of gravid hamsters with ENU led to
melanomas in the offspring. Respiratory
tumors have been observed in many mouse
strains and in hamsters after prenatal exposure
to a wide variety of direct-acting mutagens,
including X ray, DMBA, urethane, ENU, and
NDEA, among others. Likewise, ovarian and
uterine tumors have been caused in mice by
gestational exposure to X ray, DMBA, ure-
thane, and ENU. In addition to lymphoid
neoplasms in mice by X rays, urethane,
DMBA, and ENU, among others, the same
tumor type was caused by prenatal exposure of
dogs to radiation. Prenatal ENU led to ner-
vous system tumors in mice, rats, hamsters,
opossums, and rabbits, and to kidney tumors
in mice, rats, hamsters, rabbits, and opossums.
Prenatal X ray led to pituitary tumors in mice;
DMBA caused forestomach tumors in mice,
whereas ENU caused intestinal tumors in mice
and pancreatic tumors in rats. Liver tumors
were caused in mouse, hamster, and rat off-
spring after gestational exposure to X rays, ure-
thane, and ENU. In addition, transplacental
ENU exposure led to a higher incidence of
multiple tumor types in the offspring than
when the ENU was given to juvenile patas
monkeys (Rice et al. 1989).
Along with gestation, other critical periods
of offspring development have been examined
for carcinogenic toxicant effects. Several care-
fully conducted studies have examined the car-
cinogenicity of the industrial chemical ethylene
thiourea (ETU) (Chhabra et al. 1992) and the
antiseizure medication diphenylhydantoin
(DPH) (Chhabra et al. 1993a) in adult rats
and mice with or without perinatal exposure.
The objective of these studies was to determine
whether incorporating exposure during the
perinatal period in addition to adult lifetime
exposure would enhance the sensitivity of the
testing protocol to identify carcinogenic poten-
tial. In both series of studies, the maternal
rodents were exposed before breeding and
throughout gestation, lactation, and weaning,
and the resulting offspring were exposed in the
diet until 8 weeks of age (perinatal); the
rodents were exposed for 2 years starting at 8
weeks of age (adult). In a third group, the
rodent exposure was both perinatal and 2 years
of adult exposure. Whereas perinatal exposure
to DPH alone was only weakly hepatocarcino-
genic in female mice, combined perinatal and
adult exposure led to a signiﬁcant increase in
liver tumors in male mice compared with adult
exposure alone. No effect of perinatal exposure
alone was seen in rats for that compound. In
the studies involving ETU, perinatal exposure
alone was not carcinogenic in rats or mice.
However, whereas adult exposure caused thy-
roid tumors in both rats and mice, the com-
bined exposure regime—i.e., perinatal and
adult—further increased the number of ETU-
induced thyroid tumors in rats. In neither of
these studies did the use of the perinatal expo-
sure paradigm alter the tumor latency period.
However, perinatal exposure combined with
adult exposure did lead to an enhanced num-
ber of tumors in mice in one case and rats in
another, suggesting that not only critical peri-
ods of development but length of exposure are
important for some compounds.
An exposure paradigm similar to that of
ETU and DPH was used to examine the car-
cinogenicity of polybrominated biphenyls
(PBBs), a commercial mixture used as a ﬂame
retardant (Chhabra et al. 1993b). In this
instance, perinatal exposure alone did lead to
an increase in liver tumors in both male rats
and male and female mice, as did adult expo-
sure alone in all four treatment groups.
Combined perinatal and adult exposure
enhanced the incidence of liver tumors rela-
tive to adult-only exposure. These results
conﬁrm and extend an earlier study demon-
strating a weak carcinogenic effect in rats
exposed to PBBs during gestation (Groce
and Kimbrough 1984).
Finally, it must be considered that
although several studies may demonstrate that
a particular life stage is important for adult
end points, the applicability to human disease
may differ by species because of dose sensitiv-
ity, tissue-speciﬁc differences, or differences in
the hormonal milieu. For example, there is
consistent evidence that in utero and immedi-
ate post utero exposure of rats to the artiﬁcial
sweetener saccharin results in an increase in
bladder tumors when compared with adult
exposure only (Taylor et al. 1980), and that in
second-generation saccharin-exposed male rats
there is a dose-dependent increase in the inci-
dence of bladder tumors (Schoenig et al.
1985). However, in review of studies of adult
rats, mice, hamsters, and humans exposed to
saccharin, it has been concluded that this
compound is safe for humans (Council on
Scientiﬁc Affairs, 1985; IARC 1999); rats are
the only species that possess the urinary pH
necessary to cause crystallization of the com-
pound in the bladder, leading to its carcino-
genic effects in that species.
Thus, as seen from all the preceding infor-
mation, industrial chemicals, drugs, and radia-
tion have been associated with an elevated
incidence of neoplasms in both experimental
animals and in humans after early life-stage
exposures. These studies also suggest that fetal
susceptibility (e.g., lack of metabolism, pro-
tective barriers not formed), sensitive popula-
tions (strain differences), and critical periods
of target-organ development are key elements
in the response to environmental carcinogens.
Endocrine Disruption
There is increasing concern for adverse health
outcomes after developmental exposure to
environmental compounds that perturb the
endocrine system (Birnbaum 1994a).
Endocrine-disrupting compounds (EDCs) can
be defined as exogenous agents that change
endocrine function and cause adverse effects at
the level of the organism, its progeny, and/or
subpopulations of organisms (U.S. EPA 1997).
Gestational and perinatal exposures to EDCs
may have long-term effects on the endocrine
system that can inﬂuence tumor development
later in life. The discovery of the transplacental
carcinogenic effect of DES, a synthetic estro-
gen originally used to prevent miscarriage,
lends support to this hypothesis. The fact that
a synthetic estrogen could cause cancer in off-
spring should not be surprising, given that ele-
vated levels of natural estrogens during
gestation have been associated with an increase
in breast cancer in the children of such women
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3,613 men suggests that prenatal DES
exposure is associated with testicular cancer
(Strohsnitter et al. 2001). The increase in tes-
ticular cancer may be related to early life-stage
exposure to environmental estrogens and/or
antiandrogens (Skakkebaek et al. 2001).
However, at this time there is little epidemio-
logic data for other hormonally mediated can-
cers after developmental exposure.
Endocrine Disruptors and
Rodent Tumors
In contrast to the limited epidemiologic data,
the amount of data demonstrating the impor-
tance of EDC effects after prenatal exposure
and their effects in adult tumor formation is
increasing in laboratory animal studies. The
animal data are particularly strong after expo-
sure to environmental estrogens. McLachlan
et al. (1980) demonstrated that prenatal
DES exposure in mice resulted in neoplasias
of the uterus and genital tract abnormalities.
A high incidence of uterine adenocarcinomas
(Newbold et al. 1990) and male reproductive
tract tumors could also be produced after acute
neonatal exposure to DES. Studies suggest that
the carcinogenic effects of DES may be trans-
mitted to succeeding generations (Newbold et
al 2000; Walker and Kurth 1995).
Genistein is a naturally occurring phyto-
estrogen found in most soy products. Although
early reports suggested beneficial effects of
such isoﬂavenoids, other studies correlate high
levels of phytoestrogen intake with adverse
health effects. Hilakivi-Clarke et al. (1999)
showed an increase in carcinogen-induced
mammary cancer in female rat offspring after
maternal genistein injection, suggesting that
an elevated estrogenic environment in utero
could increase subsequent breast cancer risk.
Exposure of late-gestation dams to genistein
resulted in enhanced sensitivity of the pups to
DMBA-induced mammary tumors at sexual
maturity. However, this result was not
repeated in another laboratory (Lamartiniere
et al. 2002) when genistein was administered
orally. Whether this is solely a function of
dose or compound availability remains to be
determined. Newbold et al. (2001) injected
neonatal mice with genistein (increased
bioavailability) and observed an incidence of
adenocarcinomas of the uterus similar to that
previously observed for DES. Although there
are differences in the route of exposure
between some of the rodent genistein studies
(injected) and human consumption (oral),
there were similar route of administration
discrepancies in DES studies comparing rodent
(injection) versus human (oral) endometrial
cancer. There was agreement between the ani-
mal and human studies in the latter case
(reviewed above). With this said, there is a dra-
matic lack of epidemiologic studies evaluating
the effect of maternal (fetal) or infant soy con-
sumption and correlation with breast, uterine,
or testicular cancer.
Tamoxifen, regarded as an estrogen antago-
nist in the adult breast but an agonist during
development and in the adult liver, also acted
in an estrogenic manner in the developing
mammary gland. Exposure of the rat to tamox-
ifen during late gestation resulted in enhanced
sensitivity to DMBA-induced breast cancer in
the offspring at maturity (Hilakivi-Clarke et al.
2000). This was similar to the response previ-
ously observed with injected genistein.
The PBBs, possessing multiple endocrine-
modulatory effects including estrogenic pertur-
bation, are associated with an increase in liver
tumors in both rats and mice after prenatal
exposure (Chhabra et al. 1993b). They belong
to a class of toxic chemicals known as poly-
halogenated aromatic hydrocarbons (PHAHs),
which includes the polyhalogenated dibenzo-p-
dioxins, dibenzofurans, biphenyls, and naph-
thalenes. The members can be chlorinated,
brominated, or have mixed chloro-bromo sub-
stitution. The PHAHs provide the best exam-
ples of persistent EDCs in the environmental
setting. Multiple examples of endocrine dis-
ruption caused by members of this class have
been observed in wildlife (fish, birds, and
mammals) and domestic animals (e.g., cows,
sheep, horses, chickens), as well as in a host of
laboratory animals, with representatives from
all vertebrate classes including nonhuman pri-
mates (Birnbaum 2000). For example, the dis-
ruption of reproduction in trout of the Great
Lakes in the United States has been associated
with exposure to dioxin (U.S. EPA 1993), and
the lack of reproduction of wild mink has been
attributed to environmentally relevant dietary
levels of polychlorinated biphenyls (PCBs)
(Brunstrom et al. 2001).
Dioxin-Induced Changes 
in Health
The term “dioxins” is used for members of the
PHAHs that are structurally related (have simi-
lar halogen substitution patterns), are persistent
and bioaccumulative, and have a common spec-
trum of biologic responses mediated via binding
to a speciﬁc high-afﬁnity cellular protein, the
aryl hydrocarbon (Ah) receptor (Van den Berg
et al. 1998). The prototype chemical for this
class is dioxin, or 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD). Often called the most toxic
man-made compound, dioxin can cause a host
of effects. Although essentially all vertebrates are
sensitive to its effects, not every effect may occur
in all species. In addition, many of the responses
are developmental stage- or sex-dependent.
Dioxins are developmental and reproduc-
tive toxicants and cause immunotoxicity,
dermal and hepatic toxicity, a plethora of
endocrine effects, and cancer (Birnbaum
1994b). Dioxins cause effects at all levels of
biologic organization from the molecular
level to biochemical changes affecting metab-
olism, cellular communication, and tissue and
organ function. Many of the effects of dioxins
in tissues and organs are associated with alter-
ations in proliferation, differentiation, and
homeostasis. Dioxins perturb many hormone
systems, and depending on the system, the
effects may be at the level of the receptor,
with either an increase or decrease in the
receptor number (e.g., exposure-induced
decrease in glucocorticoid receptor number in
the liver vs. an increase in that receptor in the
developing palate) (Abbott et al. 1994; Lin et
al. 1991). TCDD can alter the metabolism of
hormones, e.g., estrogen, via the induction of
biotransformation enzymes (Safe et al. 1998).
Dioxins can also alter the transport of hor-
mones by affecting protein binding in the
blood, e.g., thyroid hormone transport by
transthyretin (Birnbaum 1994b). In addition
to effects on classical hormonal systems, diox-
ins perturb multiple growth factors, their
receptors, and their downstream cell-signaling
cascades. These growth factors include EGF,
TGFα, EGF receptor, TGFβ, vitamin A, and
multiple cytokines, specific interferons and
interleukins, as well as signal-transduction
components such as those involving tyrosine
phosphorylation and calcium mobilization
(Birnbaum and Tuomisto 2000).
In addition to its actions as an endocrine
disruptor, TCDD is a known human carcino-
gen (IARC 1997; U.S. Department of Health
and Human Services 2000; U.S. EPA 2001),
causing an increase in total cancers. Several
occupational studies suggest that dioxin expo-
sure is associated with an increase in lung cancer
(reviewed in above references). Additional can-
cers reported after dioxin exposure include
hematologic cancers and soft-tissue sarcomas. At
least 18 studies have been published on animal
cancer in rats, mice, hamsters, and ﬁsh, demon-
strating cancer-positive outcomes in both sexes
and at multiple sites. Experimental studies have
also demonstrated that dioxins are potent tumor
promoters, enhancing both the incidence and
multiplicity of tumors at multiple sites after ini-
tiation with a direct-acting mutagen.
The breast is a key tumor-forming organ
for which there is apparently conflicting
information. The human data are not yet
clear, although a recent Seveso, Italy, cohort
study demonstrates a significant increase in
breast cancer in association with elevated
serum levels of dioxin (Warner et al. 2002).
An earlier ecologic epidemiologic study on
the Seveso population suggested there might
be a nonsigniﬁcant decrease in the incidence
of breast cancer (Bertazzi 1993). In only one
of the 17 lifetime rodent studies (Kociba et al.
1978) was there a decrease in the incidence of
mammary tumors. However, in certain in
vivo situations dioxin can be antiestrogenic
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systems dioxin can downregulate the estrogen
receptor, resulting in antiestrogenic properties
(Gierthy et al. 1993). In contrast, a number of
TCDD responses, such as liver tumors in rats
and endometriosis in rodents and monkeys,
require the presence of estrogen (Birnbaum
and Cummings 2002; Lucier et al. 1991).
Prenatal Endocrine Disruption
and Mammary Tumors
The model used to demonstrate the prenatal
effects of tamoxifen and genistein on the
DMBA induction of breast tumors in the
adult was used by Brown et al. (1998) with
TCDD. These investigators exposed rats pre-
natally to a single oral dose of TCDD, cross-
fostered the animals to eliminate lactation
exposure, and treated the pups at sexual matu-
rity with DMBA. The prenatal TCDD treat-
ment led to twice as many mammary tumors
several months later. This raises the question of
how prenatal TCDD increases the sensitivity
of the pups to DMBA-induced mammary can-
cer. Brown and co-workers did not observe
any effects on estrus cyclicity or any evidence
of clear estrogenicity of the dioxin treatment,
but did note an increased number of terminal
end bud structures at the time of DMBA
exposure, suggesting that TCDD delayed
gland maturation.
The Ah receptor, which is required for
dioxin’s effects, is present during organogenesis
in most tissues (Abbott et al. 1995). It contin-
ues to be expressed in the mammary gland of
the pubescent rodent and is localized to the
mammary ducts and developing lobules
(Hushka et al. 1998). In addition, these
authors demonstrated that mice in which the
Ah receptor has been eliminated display
decreased mammary gland size and suppressed
lobule development, suggesting a critical role
of the Ah receptor in normal and TCDD-
exposed mammary gland development.
The rodent mammary gland begins
formation as an epithelial bud late in fetal
development. The epithelial cells then grow
out over the underlying mesenchymal fat pad,
leading to an extensive development of ducts
with terminal end buds. Following puberty,
these terminal end buds differentiate into lob-
ules [reviewed by Fenton et al. (2002)].
Although it has been known for several years
that prenatal TCDD can decrease pup body
weight, delay vaginal opening, and lead to the
induction of persistent vaginal thread (Flaws
et al. 1997; Gray and Ostby 1995; Gray et al.
1997), the work of Brown et al. (1998) was
the ﬁrst to demonstrate an effect of TCDD on
mammary tissue such as an increase in num-
ber of terminal end buds at sexual maturity, a
time when in controls they have mostly differ-
entiated into lobules (the precursor structures
needed for future lactation).
Recent work (Fenton et al. 2002) has
demonstrated that in utero exposure to
TCDD (1 µg/kg) in rats causes changes in
the mammary gland of the offspring, includ-
ing fewer primary ducts, stunted epithelial
progression into the fat pad, fewer than half
the number of terminal buds than in control
glands, decreased lateral ductal branching,
delayed lobule formation, and the presence of
terminal end buds at a time when control
glands have few. It is important to note that
terminal end buds are sensitive to tumor initi-
ation, because they are undergoing rapid pro-
liferation and differentiation, and it is widely
believed that the stage of development is key
in susceptibility to carcinogenesis (Russo and
Russo 1978). Although Brown et al. (1998)
were unable to detect any morphologic differ-
ence in the prenatally treated mammary glands
at weaning, the more recent studies detected
alterations in mammary gland development as
early as postnatal day (PND) 4 (Fenton et al.
2002). Prenatal dioxin exposure, in the latter
studies, also led to the absence of full matura-
tion of the gland, with no evidence that the
mammary gland ever recovered. Because
Brown et al. (1998) cross-fostered their rats
after birth, the possibility existed that lacta-
tional exposure was necessary for the very early
effects of dioxin noted in Fenton et al. (2002).
Therefore, the critical window for these dioxin
effects was identified. Pregnant rats were
exposed to TCDD (1 µg/kg) at the end of
organogenesis [gestation day (GD) 15], just
before birth (GD 20), and several days after
birth, and the offspring mammary gland was
examined at weaning. The lack of epithelial
outgrowth and decreased branching was evi-
dent only when the exposure occurred in late
organogenesis (GD 15), and not after. The
GD-15, but not GD-20, dose administration
was during a critical phase of mammary bud
outgrowth and led to fetal reprogramming of
the gland development.
There are functional consequences of
dioxin exposure, in addition to the enhanced
sensitivity to carcinogens shown by Brown et
al. (1998), to this alteration in mammary
gland structure. Data reported by Rogan et al.
(1987) suggested there was a negative correla-
tion between duration of lactation and mea-
sured serum PCB levels in a group of North
Carolina women. In a two-generational study
(Fenton et al. 2000), sexually mature, prena-
tally exposed female Long Evans rat offspring
were bred with control males and evaluated for
second-generation effects. To assess the lacta-
tional ability of first-generation rodent pups
exposed to TCDD in utero, a lactational chal-
lenge was conducted on dams with equal-sized
litters on PND 10. Dams were removed from
the pups for a set amount of time, pups were
weighed, dams were returned for a 30-min
suckling period, again they were removed, and
pups were reweighed. The control pups gained
nearly four times more weight during the short
suckling period than did the dioxin-exposed
offspring (Fenton et al. 2000). Further exami-
nation revealed that not only did the dioxin
second-generation pups have disrupted mam-
mary gland development, but also exhibited an
increase in pituitary weight. This preliminary
ﬁnding is interesting, given that dioxin expo-
sure of the original dams caused a decrease in
serum prolactin levels. A decrease in maternal
prolactin is potentially responsible for the
decrease in lactation, but may also be associated
with an increase in circulating estrogen levels.
Could elevated maternal estrogen be associated
with the enhanced sensitivity to carcinogens? Is
the lack of milk-borne prolactin important in
development of the mammary gland in
TCDD-exposed offspring? Regardless of the
actual mechanisms, prenatal TCDD appears
to alter the proliferation and differentiation of
the mammary gland, prolonging the window
of sensitivity to carcinogenesis. Whether the
same mechanism is involved in the increase in
number and incidence of methylnitrosourea
(MNU)-initiated tumors after neonatal TCDD
exposure on PND 18 (Desaulniers et al. 2001)
remains to be determined. These investigators
also demonstrated that a mixture of other
organochlorines, including PCBs, could
increase the number of MNU-initiated tumors
when the mixture was given neonatally.
Atrazine—Another
Developmental Toxicant 
of the Mammary Gland
The chlorotriazine herbicides currently repre-
sent the most heavily used of all agricultural
pesticides. The most common of these chemi-
cals is atrazine (ATR), to which nearly 60% of
the population of the United States is currently
exposed daily. ATR is used to control annual
grasses and broadleaf weeds in ﬁelds of corn,
sorghum, and sugar cane, and in orchards,
among other uses [reviewed by Das et al.
(2001)]. Regulatory concerns exist because
dietary ATR caused mammary cancer in adult
Sprague-Dawley rats. However, this effect
appeared because of the induction of a prema-
ture reproductive senescence, during which
time the elevated serum estrogen levels in the
rat acted as a tumor promoter to enhance
replication in estrogen-sensitive neoplastic cells
of spontaneously initiated tumors [reviewed by
Eldridge et al. (1998)]. Cooper et al. (2000)
have shown that ATR disrupts the hypothala-
mic control of pituitary–ovarian function,
including a decrease in circulating prolactin
and luteinizing hormone levels.
Ongoing work (Greiner et al. 2000)
demonstrated that ATR exposure altered
pubertal mammary gland development. In
fact, oral ATR administration inhibited differ-
entiation of the mammary epithelium in
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levels of estradiol and progesterone. Further
studies (Fenton S. Unpublished data) in which
pregnant rats were exposed to ATR during late
gestation (postorganogenesis) suggest a delay in
normal epithelial progression into the fat pad,
detected as early as PND 4. This delay in
gland development was evident after sexual
maturity and led to an increased presence of
terminal end buds, structures sensitive to car-
cinogen in TCDD studies (Brown et al.
1998). Therefore, ATR exposure in utero not
only delays early mammary gland development
in female offspring, but may also confer an
extended window of sensitivity to potential
carcinogens after sexual maturity. Delayed
mammary gland development of the offspring
may be triggered by the altered hormonal
milieu of the exposed dam in addition to any
direct effect of the exposure on the offspring.
A comparison of mammary gland whole
mounts from the same postnatal days in
TCDD- and ATR-exposed female rat off-
spring is shown with control tissue in Figure 1.
Are there parallels between the in utero effects
of TCDD and ATR on mammary gland
development, as well as on the susceptibility of
the offspring to any carcinogen-initiated
tumorigenesis? Both compounds alter the
endocrine status of the dam (Cooper et al.
2000; Fenton et al. 2002). These EDCs alter
migration of the epithelium into the neonatal
mammary fat pad and delay or persistently
alter mammary gland development, and in
doing so they lengthen the window of sensitiv-
ity to potential carcinogens. Whether the
actual mechanism underlying these alterations
in structure and susceptibility are the same
remains to be determined, as is any similarity
of these mechanisms in humans.
More EDCs that Potentiate
Changes in Mammary
Development
Recently, Markey et al. (2001) demonstrated
that in utero exposure of mice to bisphenol A
leads to alterations in mammary gland devel-
opment in the mouse. Not only did they see a
decrease in ductal migration of the epithelium
into the stromal compartment, but they also
noted a permanent increase in the number of
terminal ducts and terminal end buds. Such
changes are associated with enhanced suscepti-
bility to carcinogenesis in both rodents and
adults and are reminiscent of the changes
reported above for both TCDD (Fenton
et al. 2000, 2002) and ATR (Fenton S.
Unpublished data). Preliminary reports from
Waalkes et al. (In Press) have demonstrated
that gestational exposure of mice to arsenic
results in tumors in multiple tissues in the off-
spring followed for 104 weeks. In addition to
lung and liver tumors, target sites for arsenic
carcinogenesis in humans, the pattern of
tumors resemble that seen after developmental
exposures to estrogens: liver and adrenal
tumors in males; ovarian, oviduct, and uterine
tumors in females. Whether this apparent
estrogenic effect of arsenic is due to the up-
regulation of estrogen receptor alpha, as
observed in mouse liver after chronic exposure
(Chen et al. 2002), remains to be determined.
Human Impact?
All of these studies have demonstrated that pre-
natal exposure to EDCs can alter the hormonal
milieu, reproductive tissue development, and
susceptibility to potential carcinogen exposure
in the adult. These compounds are not geno-
toxic, yet can have signiﬁcant adverse health
outcomes. Interestingly, dioxin exposure was
recently shown to be associated with a delay
in breast development in girls (Den Hond et
al. 2002). We must ask these questions: Are
the appropriate, sensitive animal strains being
used to test for endocrinologically based dis-
eases, such as breast cancer? Are many of the
adult rodents whose brain and endocrine
function are fully developed relatively insensi-
tive when exposed to EDCs as adults? There
have been epidemiologic studies investigating
the association of environmental chemicals,
including both organochlorines, such as
PCBs and ATR, with breast cancer incidence
(Sasco 2001). These particular studies have
measured the levels of exposure of these
chemicals in adult women who develop breast
cancer. Could we be trying to correlate expo-
sure and effect at the wrong time? If it is pre-
natal or early life-stage exposure that is critical
to disease susceptibility, why are we measur-
ing environmental chemicals in people once
they have developed breast cancer? The criti-
cal exposure window may have occurred
much earlier.
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